Document is current
Any future updates will be listed below
-
Authors
Antico, Odetta
Thompson, Paul W.
Hertz, Nicholas T.
Muqit, Miratul M. K.
Parton, Laura E. https://orcid.org/0009-0000-0818-0446
- License Information
-
More Information
Article History
Accepted: 25 November 2024
First Online: 14 January 2025
Competing interests
: O.A. declares no completing interests. M.M.K.M. is a member of the Scientific Advisory Board of Montara Therapeutics Inc. and scientific consultant to Merck, Sharp and Dohme. P.W.T. is a Mission Therapeutics share option holder. N.T.H. was co-founder and Chief Scientific Officer at Mitokinin, a company that developed PINK1 activators. L.E.P. is a Mission Therapeutics share option holder.
